Summary
Reports indicate that some users of the Dexcom G7 continuous glucose monitor (CGM) are experiencing inaccurate blood sugar readings, which has led to dangerous situations for people with Type 1 diabetes. Despite these issues, Dexcom, a company known for developing CGMs, states confidence in their product and offers replacements for confirmed faulty sensors. Users have expressed significant concern and frustration, leading some to revert to previous models or seek alternative methods for monitoring glucose levels.
Key Facts
- People with Type 1 diabetes make many daily health decisions and often use continuous glucose monitors (CGMs) to track blood sugar.
- The Dexcom G7, a CGM device, is supposed to provide real-time glucose readings.
- Users have reported errors in the G7's readings, like showing incorrect high or low blood sugar levels.
- These inaccurate readings have caused fear and health risks among users.
- Dexcom acknowledges product issues but defends the device's accuracy and offers sensor replacements.
- Some users, due to the G7's problems, have switched back to older models or used other methods like service dogs.
- A reported pattern showed a 70% failure rate in reviewed user experiences.
